Skip to content
GCC AI Research

Search

Results for "Malaria"

AI to reduce malaria in a warming world

MBZUAI ·

MBZUAI is developing AI-powered applications to help reduce malaria's impact in Indonesia, supported by Sheikh Mohamed bin Zayed Al Nahyan's Reaching the Last Mile initiative. The applications use sensory data fusion to create "digital twins" for precise weather forecasting and real-time environmental representation. AI and clustering analysis identify recurring features contributing to malaria outbreaks, enabling preventative measures and early treatment. Why it matters: This project demonstrates AI's potential in combating climate-sensitive diseases and improving public health in vulnerable regions.

Supporting malaria solutions

MBZUAI ·

Malaria No More, the Crown Prince Court of Abu Dhabi, and the Reaching the Last Mile program launched the Institute for Malaria and Climate Solutions (IMACS) to combat malaria amidst climate change. Mohamed Bin Zayed University for Artificial Intelligence (MBZUAI) joined as a technical partner, providing research support leveraging AI and data science. The initiative aims to develop and implement AI-driven strategies to address the impact of climate change on malaria transmission. Why it matters: This partnership highlights the UAE's commitment to using AI for global health challenges, particularly in combating climate-sensitive diseases like malaria.

Biweekly research update

KAUST ·

Professor Arnab Pain's group at KAUST discovered new insights on how a malaria protein enables parasites to spread malaria in human cells. Professor Haavard Rue's group upgraded the Integrated and Nested Laplace Approximation (INLA) for faster real-time modeling of large datasets. A KAUST-led study examined the stability of Y-series nonfullerene acceptors for organic solar cells. Why it matters: KAUST continues producing impactful research across diverse fields from medicine to climate change, advancing scientific knowledge and potential applications.

Alumnus receives Marie Skłodowska-Curie Fellowship

KAUST ·

KAUST alumnus Abhinay Ramaprasad (M.S. '12, Ph.D. '17) has been awarded the Marie Skłodowska-Curie Fellowship from the European Commission. He will research malaria at the Francis Crick Institute in the U.K., focusing on the mechanisms of malaria parasite egress from red blood cells. Ramaprasad credits his time at KAUST and his work in Professor Arnab Pain's laboratory for preparing him for this opportunity. Why it matters: This fellowship recognizes the high-quality research training at KAUST and supports important work in combating a disease prevalent in many regions, reflecting KAUST's impact on global health.

MNM, RLM, and MBZUAI sign expansion of climate and health initiative

MBZUAI ·

Malaria No More (MNM), Reaching the Last Mile (RLM), and MBZUAI have signed an agreement to expand the Forecasting Healthy Futures (FHF) initiative with a $5 million award from RLM. The initiative aims to address the impact of climate change on malaria and other climate-sensitive infectious diseases. MBZUAI will provide expertise to support the eradication of malaria. Why it matters: This partnership highlights the UAE's commitment to global health and leverages AI to combat climate-sensitive diseases, demonstrating a proactive approach to addressing complex global challenges.

Unlocking coronavirus' secrets through cellphone data and social media

KAUST ·

A KAUST research team is using cellphone mobility data, Google searches, and social media to model and predict COVID-19 spread. The models aim to forecast cases in the coming weeks and inform resource allocation, including hospital beds and medical staff. The team is using aggregated and anonymized data from cellphone companies to respect people's privacy. Why it matters: Integrating real-time digital data with epidemiological modeling can improve the speed and effectiveness of public health responses in the region and globally.

Shining a light on the SARS-CoV-2 virus

KAUST ·

The KAUST Pathogen Genomics Laboratory (PGL), led by Professor Arnab Pain, is using DNA and RNA sequencing to study the SARS-CoV-2 virus. The lab is part of KAUST's Rapid Research Response Team (R3T), supporting Saudi healthcare stakeholders in combating COVID-19. Pain and his Ph.D. student Sharif Hala are partnering with the Saudi-CDC and Ministry of Health hospitals to sequence Saudi SARS-CoV-2 samples. Why it matters: This effort provides crucial data for understanding and monitoring the virus's spread and evolution within the Kingdom, informing public health strategies.

KAUST receives Gates Foundation grant for parasitic weed research

KAUST ·

KAUST has received a $1.5 million grant from the Gates Foundation to research methods for eradicating the Striga hermonthica weed, also known as "witchweed". This parasitic plant devastates crops in sub-Saharan Africa by depleting water and nutrients, with the project led by Dr. Salim Al-Babili focusing on pearl millet. The research will involve collaboration with universities in Burkina Faso, Japan, and the Netherlands to identify biological compounds and low-cost methods for Striga control. Why it matters: Addressing Striga infestations is crucial for enhancing food security and supporting the livelihoods of millions of farmers in Africa and the Middle East who rely on crops like pearl millet.